Please login to the form below
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region
Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
Targeting largest family of proteins in cell membranes
Recursion raises $121m for AI-led drug discovery
Funds will fuel in house pipeline and tech
AbbVie cures STING fever with Mavupharma acquisition
Joins host of companies pursuing novel mechanism
Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms
Latest BACE inhibitor to run into trouble
ViiV builds case for switching to its two-drug HIV combinations
Taking aim at rival Biktarvy
Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease
Treatment can help patients with advanced disease, companies say
UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D
Pilot much more to industry liking, but devil will be in detail
Boehringer tests speech as early warning for CNS diseases
Company extends foray into digital health innovation
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
New results back Sangamo, UniQure haemophilia gene therapiesEncouraging results for firms in four-way race
-
Citryll snares €15m backing for its autoimmune disease NETsNew approach to tackling diseases such as lupus, RA
-
Hesperos’ ‘human-on-a-chip’ predicts drug toxicity in the labDrug discovery potential
-
Boehringer bolsters NASH pipeline with $870m Yuhan dealStrengthens existing relationship
-
Amicus forms gene therapy manufacturing partnership with CatalentBiotech invests to speed gene therapies into clinical trials
-
Tiziana joins type 1 diabetes prevention fieldCites potential advantages
-
Rivals rise as safety issue mars Pfizer’s DMD gene therapy trialCompany to press ahead with phase 3 trial
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
-
Metrion Biosciences establishes scientific advisory board
The board will provide scientific oversight and strategic advice to Metrion
-
Dr Sotirios Stergiopoulos leaves Shire for IpsenHe becomes the French biopharma’s chief medical officer
-
Linda Law joins Advicenne as US VP, clinical development and med affairsShe will oversee the biopharma’s developments with its dTRA candidate
Latest research appointments
Featured jobs
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- Communique Awards 2019: Photo Gallery - Communiqué Awards
- AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
- Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms
- AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
- Moving annual total (MAT)
- Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms
- We are Gold! Porterhouse Medical Group is recognised as an ‘Investor in People’ at the Gold level
- Illumina sets up first ex-US accelerator site in Cambridge
- Kisqali combination follows Verzenio onto Cancer Drugs Fund
- Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
- ACPs to lead gene therapies in haemophilia market growth
- FDA starts speedy review of Novartis’ sickle cell antibody
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
